About the Company
Odonate Therapeutics, Inc. is a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer. Odonate’s initial focus is on the development of tesetaxel, an investigational, orally administered chemotherapy agent that belongs to a class of drugs known as taxanes, which are widely used in the treatment of cancer. Odonate’s goal for tesetaxel is to develop an effective chemotherapy choice for patients that provides quality-of-life advantages over current alternatives.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ODT News
FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin ...
ATXS Astria Therapeutics, Inc.
Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States.
Omega Therapeutics Inc OMGA
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
TG Therapeutics Inc TGTX
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Is About To Turn The Corner
Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Aldeyra Therapeutics, Inc., a ...
Esperion Therapeutics, Inc. (ESPR)
and MUNICH, Germany, March 22, 2024 (GLOBE NEWSWIRE) -- Daiichi Sankyo Europe GmbH (hereafter, ‘Daiichi Sankyo’) and Esperion Therapeutics, Inc. jointly announced today, that the Committ In ...
Vivos Therapeutics Inc (VVOS)
Vivos Therapeutics, Inc. (VVOS), a medical technology company specializing in the treatment of obstructive sleep apnea (OSA), held its Fourth Quarter and Full Year ...
Fate Therapeutics, Inc.
Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno ...
Jasper Therapeutics, Inc. (JSPR) Is Up 24.77% in One Week: What You Should Know
Below, we take a look at Jasper Therapeutics, Inc. (JSPR), a company that currently holds a Momentum Style Score of B. We also talk about price change and earnings estimate revisions, two of the ...
Intellia Therapeutics, Inc.
Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms ...
Loading the latest forecasts...